Combination of Hydroquinone and Fractional CO2 Laser versus Hydroquinone Monotherapy in Melasma Treatment: A Randomized, Single-blinded, Split-face Clinical Trial

被引:10
作者
Abadchi, Sanaz Nourmohammadi [1 ]
Naeini, Farahnaz Fatemi [1 ]
Beheshtian, Elham [1 ]
机构
[1] Isfahan Univ Med Sci, Dept Dermatol, Esfahan, Iran
关键词
Fractional CO2 laser; hydroquinone; melasma; INTENSE PULSED-LIGHT; TOPICAL THERAPY; LASER TREATMENT; GLYCOLIC ACID; EFFICACY; DELIVERY; PEELS;
D O I
10.4103/ijd.IJD_240_17
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Melasma is a chronic hyperpigmentation skin disorder mainly affecting women in the reproductive age. Available treatments for melasma do not lead to long-term satisfactory results. Aims: This study aimed to compare the efficacy of fractional CO2 laser in combination with topical therapy to topical therapy alone. Materials and Methods: Forty women with bilateral melasma were studied in this randomized single-blinded clinical trial. Each side of the face was randomly allotted to either topical hydroquinone 4% or combination of topical hydroquinone 4% and fractional CO2 laser. Patients received three sessions of laser therapy at 3-week intervals. Hydroquinone 4% application on both sides maintained for 3 months after the last laser session. The clinical improvement (darkness [D] and homogeneity [H] of hyperpigmentation) was measured by a blinded main investigator and an outcome assessor. Furthermore, improvement was assessed by physician's global assessment (PGA) and patient satisfaction (visual analog scale [VAS] score). Results: Significant reduction in D observed 3 weeks after combination therapy (p<0.001) and 6 weeks after monotherapy (P<0.001). Reduction in H became significant after 6 weeks in both groups (p<0.001). However, the two methods were not considerably different in any session (P>0.05). Furthermore, control and experiment sides were not significantly different considering VAS score and PGA (P>0.05). Conclusion: Considering the short-term outcome of laser and hydroquinone therapy, we can apply it to obtain earlier positive results. However, because of the lack of significant difference between the two methods and also the high cost of laser therapy, it seems better not to recommend fractional CO2 laser to patients as adjunctive therapy for long-term treatment of melasma.
引用
收藏
页码:129 / 135
页数:7
相关论文
共 36 条
[1]  
Achar Arun, 2011, Indian J Dermatol, V56, P380, DOI 10.4103/0019-5154.84722
[2]  
Arora Pooja, 2012, J Cutan Aesthet Surg, V5, P93, DOI 10.4103/0974-2077.99436
[3]   Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology [J].
Chen, Xinyuan ;
Shah, Dilip ;
Kositratna, Garuna ;
Manstein, Dieter ;
Anderson, Richard R. ;
Wu, Mei X. .
JOURNAL OF CONTROLLED RELEASE, 2012, 159 (01) :43-51
[4]  
Ghosh SK, 2009, INDIAN J DERMATOL VE, V75, P306, DOI [10.4103/0378-6323.51269, 10.4103/0019-5154.57602]
[5]   Melasma and laser treatment: an evidenced-based analysis [J].
Halachmi, Shlomit ;
Haedersdal, Merete ;
Lapidoth, Moshe .
LASERS IN MEDICAL SCIENCE, 2014, 29 (02) :589-598
[6]   Melasma: a clinical and epidemiological review [J].
Handel, Ana Carolina ;
Bartoli Miot, Luciane Donida ;
Miot, Helio Amante .
ANAIS BRASILEIROS DE DERMATOLOGIA, 2014, 89 (05) :771-782
[7]   Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma [J].
Ibrahim, Zeinab A. ;
Gheida, Shereen F. ;
El Maghraby, Gamal M. ;
Farag, Zeinab E. .
JOURNAL OF COSMETIC DERMATOLOGY, 2015, 14 (02) :113-123
[8]   Treatment of Melasma Using Fractional Photothermolysis: A Report of Eight Cases with Long-Term Follow-Up [J].
Katz, Tracy M. ;
Glaich, Adrienne S. ;
Goldberg, Leonard H. ;
Firoz, Bahar F. ;
Dai, Tianhong ;
Friedman, Paul M. .
DERMATOLOGIC SURGERY, 2010, 36 (08) :1273-1280
[9]   Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers [J].
Kauvar, Arielle N. B. .
LASERS IN SURGERY AND MEDICINE, 2012, 44 (02) :117-124
[10]  
KLIGMAN AM, 1975, ARCH DERMATOL, V111, P40